Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt

By Emily Lever · October 10, 2024, 5:45 PM EDT

Vaccine developer Gritstone bio Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday with at least $100 million of debt, saying it was in discussions with a potential bidder...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

A vaccine developer focused on preventative treatments for cancer and HIV filed for bankruptcy with plans to find a buyer in Chapter 11 that will continue its research.

Case Number

24-bk-12305

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$100 million to $500 million

View Full Scorecard

Documents

Petition

Recent Articles By Emily

December 20, 2024
World Of Beer Brews Up Ch. 11 Plan Cramdown
December 19, 2024
Silvergate Wins Fight To Keep Control Of Ch. 11 Case
December 18, 2024
Steward Health Docs Say $60M Comp Plan Off-Limits
December 17, 2024
Catching Up With New Bankruptcy Case Action
December 16, 2024
Judge Kills Infowars Sale, BigLaw Firms Duck Suit
December 13, 2024
Cardi B Tries To Sink Ch. 11 Of YouTuber Who Owes Her $3.8M
December 13, 2024
Manhattan Clinic Hits Ch. 11 With Up To $10M Debt
December 12, 2024
Ch. 7 Trustee Must Explain $200M Holdback Bid, Court Told
December 11, 2024
US Trustee Wants To Pump Brakes On Spirit Airlines Ch. 11
December 11, 2024
FTX Settles With Congressional PACs In Ch. 11